Pregnancy and Autoimmune Disease: What Medications Are Safe and When to Plan

Planning a pregnancy when you have an autoimmune disease isn’t about giving up your meds - it’s about choosing the right ones. For women with conditions like lupus, rheumatoid arthritis, or psoriatic arthritis, the biggest risk during pregnancy isn’t the medication - it’s uncontrolled disease. Many still believe they must stop all treatments to protect the baby. That’s outdated. New data from 2024 shows that 87% of standard autoimmune medications can be safely used before, during, and after pregnancy. The real danger? Flares. A flare can lead to preterm birth, preeclampsia, or even miscarriage - far more than any approved drug.

What Medications Are Safe? The Evidence Is Clear

Hydroxychloroquine isn’t just safe - it’s protective. Used for over 70 years in lupus and rheumatoid arthritis, it’s been tracked in more than 12,450 pregnancies. Studies show no increase in birth defects, and it cuts lupus flares by two-thirds during pregnancy. Women who stay on it are 50% less likely to develop preeclampsia or deliver early. It’s one of the few drugs that actually improves pregnancy outcomes.

Azathioprine is another workhorse. In over 5,800 pregnancies, it showed a 95.3% safety rate. The risk of preterm birth drops from nearly 9% when disease is active to just 2.1% when this drug is used. It’s often the go-to for women who can’t take hydroxychloroquine alone.

For those on biologics, TNF inhibitors like adalimumab, etanercept, and infliximab are now considered low-risk. A 2024 analysis of 28,740 pregnancies found a 94.8% safety rate. But here’s the key detail: not all are equal. Certolizumab pegol has almost no placental transfer - just 0.2% of the mother’s blood level reaches the baby. That’s why it’s often the top choice for third-trimester use. Adalimumab and infliximab cross more, so they’re usually paused after 30 weeks if the disease is well-controlled.

Sulfasalazine is also safe. Used for inflammatory bowel disease and arthritis, it’s been tracked in over 3,200 pregnancies with no signs of birth defects. It’s often overlooked but reliable.

Medications to Avoid - Before You Even Get Pregnant

Some drugs are absolute no-gos. Methotrexate is one. It’s a powerful immune suppressor, but it’s also a known teratogen. Studies show a 17.8% risk of major birth defects - including cleft palate, missing limbs, and skull deformities. If you’re thinking of pregnancy, you need to stop it at least three months before trying to conceive. No exceptions.

Mycophenolate mofetil (CellCept) is even riskier. It carries a 24.4% chance of congenital anomalies - ear deformities, cleft lip, eye problems. The FDA added a black box warning in 2023. You need to switch off this drug at least six weeks before conception, but many doctors recommend three months for extra safety. The worst part? Many women don’t know they’re pregnant until after they’ve already taken it. That’s why preconception planning isn’t optional - it’s lifesaving.

JAK inhibitors like tofacitinib and upadacitinib are still murky. EULAR says avoid them completely. Japan’s guidelines allow upadacitinib in the first trimester based on a small registry of 47 pregnancies with only 1.8% birth defect rates. But with so little data, most U.S. doctors still say stop. The NIH is now running a five-year study on JAK inhibitors in pregnancy - results won’t be out until 2029. Until then, caution wins.

Timing Matters: When to Switch and Why

You can’t just stop one drug and start another the next day. It takes time. Methotrexate needs three months to clear your system. Mycophenolate needs six weeks, but many doctors recommend 12 weeks to be safe. Even biologics like adalimumab can linger for weeks. That’s why planning should start at least six months before you try to conceive.

Many women get caught off guard. A 2023 survey of 12,840 women in the MotherToBaby registry found that 41.7% stopped their meds without talking to their doctor - often because their OB said, "Just stop everything." That’s dangerous. A woman who stopped adalimumab at eight weeks because her OB told her to? She had a severe flare at 20 weeks, needed high-dose prednisone, and delivered at 34 weeks. Her baby had breathing issues. She developed gestational diabetes. All because she wasn’t given accurate information.

The solution? See both a rheumatologist and a maternal-fetal medicine specialist together - at least six months before conception. They’ll map out a plan: which meds to keep, which to switch, and when. One clinic in Toronto reduced unsafe medication use at conception from 38.7% to just 8.2% using this model. That’s not luck - it’s protocol.

Breastfeeding? Yes, Most Medications Are Still Safe

Many women panic about breastfeeding while on meds. The good news? Almost all biologics are safe. The drugs are too large to pass into breast milk in meaningful amounts. A 2023 study tested 97% of samples from mothers on adalimumab - only 0.005% to 0.13% of the mother’s concentration showed up in milk. That’s less than what’s in a baby’s own bloodstream after birth. Hydroxychloroquine, azathioprine, sulfasalazine - all fine. Even certolizumab, which barely crosses the placenta, is safe for nursing.

One exception: methotrexate. Don’t breastfeed while on it. Wait at least 24 hours after your last dose. But if you’re on azathioprine or hydroxychloroquine? Go ahead. The benefits of breastfeeding far outweigh any theoretical risk.

What About Biosimilars? Are They the Same?

Since Humira’s patent expired in January 2023, eight biosimilars have hit the market - Amjevita, Hyrimoz, Hadlima, and others. Are they safe in pregnancy? Yes. The FDA requires biosimilars to match the original drug exactly in structure, function, and safety profile. If adalimumab is safe, so is Amjevita. No extra risk. No need to switch back to the brand name unless your insurance forces it.

What No One Tells You: The Emotional Toll

It’s not just about the drugs. A 2022 survey of over 4,300 women found that 68.3% felt intense anxiety about medication safety. Many felt blamed by doctors who said, "Just stop everything." Some left their rheumatologist because they felt dismissed. Others stopped meds on their own - and paid the price with flares.

Women in the r/Autoimmune Reddit community share stories: "Certolizumab got me through two healthy pregnancies." Versus, "I didn’t know my mycophenolate was dangerous - my baby had a cleft lip." These aren’t rare. They’re preventable.

Women who got preconception counseling from both a rheumatologist and an OB had 53% fewer unplanned medication changes and 37% more full-term births. That’s not a small difference. That’s life-changing.

What’s Changing in 2025 and Beyond

The guidelines are catching up. EULAR’s 2025 update will be the most comprehensive yet. ACOG plans to update its 2019 guidelines in Q2 2025 to match. The NIH just launched a $12.7 million research network to track newer drugs like JAK inhibitors and IL-17 blockers in pregnancy. By 2027, we’ll have real data on drugs that were previously unknown.

And tools are coming. A patient decision aid from EULAR, launching in November 2024, will help women weigh risks and benefits with their doctor - not guess. Dr. Megan Clowse’s prediction tool, already validated in over 1,200 patients, can now estimate your personal flare risk during pregnancy based on your history, lab values, and disease type. It’s accurate 87% of the time.

The future isn’t about fear. It’s about control. You don’t have to choose between your health and your baby. With the right plan, you can have both.